Lunit Completes Acquisition of Volpara Health Read more

Saving lives through technology

Cancer Screening AI

AI for cancer detection

By detecting early-stage cancers, AI enables timely management that can increase chance of survival.

Cancer Treatment AI

AI biomarker for immunotherapy

By accurately predicting treatment response, AI helps increase immunotherapy efficacy.

Research

Strong research with 200+ studies and abstracts

researches
researches
researches

Awards

World-leading technology

awards
awards
awards

Ranked 1st place in <CAMELYON Grand Challenge 2017>

Testimonials

Meet our customers: Using AI in day-to-day practices

Lunit AI to be introduced to Inje University Paik Hospital nationwide...

Providing cancer care for all

Growing users across 2,000 sites and more

Countries

48+
Global Research Partners
partners
partners
partners
partners
partners
Global Business Partners
partners
partners
partners
partners
partners

What will happen when AI professionals work for Healthcare? [ENG cc]

Kyung Hyun Cho, Interim Deputy Director at the Center for Data Science New York University

We expect to utilize Lunit's AI to usher in new precision oncology products.

Helmy Eltoukhy, CEO of Guardant Health

Learn more about Lunit

Lunit Appoints Volpara CEO Teri Thomas as Chief Business Officer of Cancer Screening Group

Jul 9, 2024 - 3 min read

Lunit to Showcase 7 Studies at ASCO 2024, including AI Innovations in HER2 Quantification, and Multimodal Predictive Models for Immunotherapy Response

May 24, 2024 - 5 min read

Lunit Completes Acquisition of Volpara: Pioneering Next-Level of AI-Driven Cancer Care

May 22, 2024 - 3 min read

Conquer cancer through AI

#Conquer #Cancer #AI

Why cancer

#Cancer #Conquer #Lunit

Digging the deep learning with Lunit AI Researcher

#Lunit #AI #Conference